Christopher J. Hasenberg, Inc Viatris Inc Transaction History
Christopher J. Hasenberg, Inc
- $221 Million
- Q2 2024
A detailed history of Christopher J. Hasenberg, Inc transactions in Viatris Inc stock. As of the latest transaction made, Christopher J. Hasenberg, Inc holds 16 shares of VTRS stock, worth $180. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16
Previous 16
-0.0%
Holding current value
$180
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding VTRS
# of Institutions
1,099Shares Held
969MCall Options Held
2.63MPut Options Held
2.15M-
Vanguard Group Inc Valley Forge, PA140MShares$1.58 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.04 Billion0.02% of portfolio
-
State Street Corp Boston, MA62.1MShares$700 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az57.5MShares$648 Million3.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD56.8MShares$640 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $13.7B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...